• Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands [Editor's Choice]

    Oct 1, 2024, 00:00

  • Author Reply

    Oct 1, 2024, 00:00

  • Mapping the Lequesne Functional Index Into the EQ-5D-5L Utility Index in Patients With Knee Osteoarthritis

    Oct 1, 2024, 00:00

  • Traditional Methods Hold Their Ground Against Machine Learning in Predicting Potentially Inappropriate Medication Use in Older Adults [Editor's Choice]

    Oct 1, 2024, 00:00

  • Generating Utilities for the Château-Santé Base: A Novel, Generic, and Patient-Centered Health-Outcome Measure

    Oct 1, 2024, 00:00

  • Predicting the Population Health Economic Impact of Current and New Cancer Treatments for Colorectal Cancer: A Data-Driven Whole Disease Simulation Model for Predicting the Number of Patients with Colorectal Cancer by Stage and Treatment Li ...

    Oct 1, 2024, 00:00

  • Integrating Price Benchmarks and Comparative Clinical Effectiveness to Inform the Medicare Drug Price Negotiation Program [Editor's Choice]

    Oct 1, 2024, 00:00

  • Cost-of/Burden-of-Illness Studies: Steps Backward?

    Oct 1, 2024, 00:00

  • Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge

    Oct 1, 2024, 00:00

  • Author Reply

    Oct 1, 2024, 00:00

  • A Tutorial on Value-Based Adaptive Designs: Could a Value-Based Sequential 2-Arm Design Have Created More Health Economic Value for the Big CACTUS Trial? [Editor's Choice]

    Oct 1, 2024, 00:00

  • Does Willingness to Pay Differ for Mental and Physical Health?

    Oct 1, 2024, 00:00

  • Sales Revenues for New Therapeutic Agents Approved by the United States Food and Drug Administration From 1995 to 2014

    Oct 1, 2024, 00:00

  • Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the European Union’s Regulation on Health Technology Assessment for Vaccines

    Oct 1, 2024, 00:00

  • Editorial Board

    Sep 27, 2024, 09:02

  • Further Evidence of Feasibility, Validity, and Reliability of Quality of Life-Aged Care Consumers: Evidence From Home-Based Care Settings

    Sep 1, 2024, 00:00

  • Facilitators and Barriers in the Implementation and Adoption of Patient-Reported Outcomes Measurements in Daily Practice

    Sep 1, 2024, 00:00

  • A Feasible Estimation of a “Corrected” EQ-5D Social Tariff

    Sep 1, 2024, 00:00

  • Experience Counts: Unveiling Patients’ Willingness to Pay for Remote Monitoring and Patient Self-Measurement

    Sep 1, 2024, 00:00

  • A Roadmap for Improving Medicare’s Application of Coverage With Evidence Development [Editor's Choice]

    Sep 1, 2024, 00:00

  • Documenting the Full Value of Vaccination: A Systematic Review of Value Frameworks [Editor's Choice]

    Sep 1, 2024, 00:00

  • Psychometric Performance of the EQ Health and Wellbeing Short in a United Kingdom Population Sample [Editor's Choice]

    Sep 1, 2024, 00:00

  • A Direct Comparison Between Discrete Choice With Duration and Composite Time Trade-Off Methods: Do They Produce Similar Results?

    Sep 1, 2024, 00:00

  • Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease

    Sep 1, 2024, 00:00

  • Table of Contents

    Sep 1, 2024, 00:00

  • Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review

    Sep 1, 2024, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI) [Editor's Choice]

    Sep 1, 2024, 00:00

  • A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices

    Sep 1, 2024, 00:00

  • Putting a Dollar Value on Informal Care Time Provided to People Living With Dementia: A Discrete Choice Experiment

    Sep 1, 2024, 00:00

  • Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian Cancer

    Sep 1, 2024, 00:00

  • Testing “Pits” Time Trade-Off: Can Data Quality be Improved by Removing Death From Valuation of Health States? [Editor's Choice]

    Sep 1, 2024, 00:00

  • Editorial Board

    Aug 27, 2024, 14:04

  • Editorial Board

    Aug 7, 2024, 11:53

  • Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®)

    Aug 1, 2024, 00:00

  • It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties [Editor's Choice]

    Aug 1, 2024, 00:00

  • Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review [Editor's Choice]

    Aug 1, 2024, 00:00

  • Table of Contents

    Aug 1, 2024, 00:00

  • The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States [Editor's Choice]

    Aug 1, 2024, 00:00

  • Can Generalized Cost-Effectiveness Analysis Leverage Meaningful Use of Novel Value Elements in Pharmacoeconomics to Inform Medicare Drug Price Negotiation?

    Aug 1, 2024, 00:00

  • Utilization, Expenditure, and Treatment Patterns Associated With Calcitonin Gene-Related Peptide Monoclonal Antibodies Reimbursed Subject to a Managed Access Protocol in Ireland

    Aug 1, 2024, 00:00

  • Navigating Public Policy Responses to a Pandemic: The Balancing Act Between Physical Health, Mental Health, and Household Income

    Aug 1, 2024, 00:00

  • Treatment Effect Waning Assumptions: A Review of National Institute of Health and Care Excellence Technology Appraisals [Editor's Choice]

    Aug 1, 2024, 00:00

  • The Long COVID Symptoms and Severity Score: Development, Validation, and Application

    Aug 1, 2024, 00:00

  • EQ-5D-5L Population Norms for China Derived From a National Health Survey

    Aug 1, 2024, 00:00

  • Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United States

    Aug 1, 2024, 00:00

  • Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma

    Aug 1, 2024, 00:00

  • Validating Health Economic Models With the Probabilistic Analysis Check dashBOARD

    Aug 1, 2024, 00:00

  • Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019

    Aug 1, 2024, 00:00

  • A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Health-Related Quality-of-Life Instruments Part I: Instrument Development and Content Validity

    Aug 1, 2024, 00:00

  • Health Fluctuations in Dementia and its Impact on the Assessment of Health-Related Quality of Life Using the EQ-5D-5L [Editor's Choice]

    Aug 1, 2024, 00:00

  • How Do the Institute for Clinical and Economic Review’s Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee’s Assessments of Added Benefit? A Qualitative Study

    Aug 1, 2024, 00:00

  • Social Decision-Making Analysis: A General Approach to Inform Decisions on Resources in the Public Sector [Editor's Choice]

    Jul 1, 2024, 00:00

  • Testing the Psychometric Properties of 9 Bolt-Ons for the EQ-5D-5L in a General Population Sample [Editor's Choice]

    Jul 1, 2024, 00:00

  • Understanding the Complex Interactions Between Interventions, Well-Being, and Resource Allocation

    Jul 1, 2024, 00:00

  • Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions

    Jul 1, 2024, 00:00

  • Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis

    Jul 1, 2024, 00:00

  • Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation

    Jul 1, 2024, 00:00

  • Values Beyond “Health” in Budget-Constrained Healthcare Systems [Editor's Choice]

    Jul 1, 2024, 00:00

  • The Ceiling Effects of EQ-5D-3L and 5L in General Population Health Surveys: A Systematic Review and Meta-Analysis

    Jul 1, 2024, 00:00

  • From Health to Well-Being: Toward a Monetary Valuation of a Well-Being-Adjusted Life-Year [Editor's Choice]

    Jul 1, 2024, 00:00

  • A Head-to-Head Comparison of EQ-HWB and EQ-5D-5L in Patients, Carers, and General Public in China

    Jul 1, 2024, 00:00

  • Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors

    Jul 1, 2024, 00:00

  • Construct Validity, Reliability, and Responsiveness of the 10-Item Well-Being Instrument for Use in Economic Evaluation Studies [Editor's Choice]

    Jul 1, 2024, 00:00

  • Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled Trial

    Jul 1, 2024, 00:00

  • Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making

    Jul 1, 2024, 00:00

  • Editorial Board

    Jul 1, 2024, 00:00

  • Comparison of the EQ-HWB and EQ-HWB-S With Other Preference-Based Measures Among United States Informal Caregivers [Editor's Choice]

    Jul 1, 2024, 00:00

  • The Measurement Properties of the EQ-HWB and the EQ-HWB-S in Italian Population: A Comparative Study With EQ-5D-5L

    Jul 1, 2024, 00:00

  • Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study

    Jul 1, 2024, 00:00

  • Table of Contents

    Jul 1, 2024, 00:00

  • Methods for Including Adverse Events in Economic Evaluations: Suggestions for Improvement

    Jul 1, 2024, 00:00

  • Subjective Well-Being Population Norms and Inequalities in Hungary: A Large Cross-Sectional, Internet-Based Survey

    Jul 1, 2024, 00:00

  • Editorial Board

    Jun 12, 2024, 08:53

  • HTA6 Use of Medical Device Assessment Criteria in CONITEC Evaluations

    Jun 1, 2024, 00:00

  • HSD121 Real-World Prescribing of Tirzepatide Labeled for Obesity in the United States

    Jun 1, 2024, 00:00

  • EE507 Frontline TKI Strategies for Chronic Myeloid Leukemia Patients: Balancing Outcomes and Costs in Pursuit of Treatment-Free Remission and Dose Reduction

    Jun 1, 2024, 00:00

  • RWD166 Evaluation of the One-Day Surgical Performance of the Hungarian Universities in the Obstetrics and Gynecology Medical Field

    Jun 1, 2024, 00:00

  • EE293 A Framework to Assess Uncertainties of Polygenic Risk Scores in Disease Screening and Prevention in Cost-Effectiveness Analyses

    Jun 1, 2024, 00:00

  • EE369 Healthcare Resource Utilization Among Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada

    Jun 1, 2024, 00:00

  • MSR69 Systematic Review and Meta-Analysis of Fecal Incontinence Prevalence and Population Estimates

    Jun 1, 2024, 00:00

  • EE19 Cost-Effectiveness Analysis of Infliximab, Adalimumab, and Certolizumab for Crohn's Disease: A Markov Model Study

    Jun 1, 2024, 00:00

  • MT15 Postoperative Clinical and Economic Outcomes of Patients With Reverse or Anatomic Total Shoulder Arthroplasty at One Year: A Retrospective, United States Hospital Billing Database Analysis

    Jun 1, 2024, 00:00

  • PCR188 Compliance and Design Features of Electronic Participant-Reported Dosing Diaries

    Jun 1, 2024, 00:00

  • HPR4 What Makes an Orphan Medicine? Determining Characteristics of Non-Oncology Orphan Approvals from 2015-2022

    Jun 1, 2024, 00:00

  • PCR196 Psychometric Validation of the PROMIS Fatigue-Short Form 7A in Adults with Newly Diagnosed or Recurrent Mycobacterium avium Complex (MAC) Lung Disease: The ARISE and ENCORE Studies

    Jun 1, 2024, 00:00

  • CO70 Comparative Bayesian Network Meta-Analysis of BTKi-Specific Adverse Events in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • SA24 CHIME2 (Chinese Hong Kong Integrated Modeling and Evaluation): An Updated Model to Simulate Lifetime Health Outcomes of Patients with Type 2 Diabetes

    Jun 1, 2024, 00:00

  • CO127 Newer Glucose-Lowering Drugs and Risk of Suicide: A Network Meta-Analysis of Randomized Outcome Trials

    Jun 1, 2024, 00:00

  • SA28 Using Linked Claims-EHR Data: The Added Value When Assessing Comorbidity Burden Among Patients With Asthma

    Jun 1, 2024, 00:00

  • EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective

    Jun 1, 2024, 00:00

  • CO206 The Clinical and Financial Impact of Sustained Annual Wellness Visit Engagement in the Blue Cross and Blue Shield of Louisiana Medicare Advantage Population

    Jun 1, 2024, 00:00

  • HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey

    Jun 1, 2024, 00:00

  • MSR9 Can Artificial Intelligence Tools Enhance Data Abstraction During Systematic Literature Reviews?

    Jun 1, 2024, 00:00

  • SA78 An Overview of Methods Employed in Economic Models of Cancer Screening Tests: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EE153 Cost-Minimization of Oral Valganciclovir Vs Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients

    Jun 1, 2024, 00:00

  • P12 Racial and Ethnic Fairness in Risk Prediction Models for Cardiovascular Diseases Among U.S. Adults

    Jun 1, 2024, 00:00

  • EE8 Targeted Literature Review for Estimating Median Age of Causal Human Papilloma Virus Infection to Oropharyngeal Cancer

    Jun 1, 2024, 00:00

  • EE485 Cost-Effectiveness of Active Surveillance for Incidentally Detected Early-Staged Papillary Thyroid Cancer: A Microsimulation Study

    Jun 1, 2024, 00:00

  • EPH119 Public Health Results in the Department of Bolívar, Colombia: An Analysis of Indicators in 2023

    Jun 1, 2024, 00:00

  • CO39 Influence of Socioeconomic Status on Breast Cancer Treatment in the US: Preliminary Results from a Systematic Literature Review

    Jun 1, 2024, 00:00

  • PCR209 Joint Modeling of Progression-Free Survival (PFS) and Patient-Reported Symptoms Among Relapsed/Refractory Multiple Myeloma (RRMM) Patients

    Jun 1, 2024, 00:00

  • HSD1 Assessing Community Pharmacist Expectation, Satisfaction, and Intentions in the Wasfaty E-Servi Using the Expectation Conformation Theory

    Jun 1, 2024, 00:00

  • MSR61 Perceptions of the Feasibility of AI-Based Machine Translation for Linguistic Validation

    Jun 1, 2024, 00:00

  • OP2 Health Insurance Cost Management: Perspective from the Caribbean Region, Colombia

    Jun 1, 2024, 00:00

  • PCR66 Improving Quality of Life in Endometriosis Patients: A Study on Lifestyle and Pain Scores

    Jun 1, 2024, 00:00

  • EPH108 Clopidogrel Resistance in Patients With Recurrent Ischaemic Stroke on Dual Antiplatelet Therapy and Its Economic Impact in a Lower-Middle Income Country: A Single Centered Study in Southern India

    Jun 1, 2024, 00:00

  • EPH213 Burden of Heart Failure After Hospitalization for Myocardial Infarction in the United States: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • EPH211 Treatment Patterns and Clinical Characteristics of Patients Diagnosed with Metastatic NSCLC in Hmo from Colombia: A Real Word Evidence Study

    Jun 1, 2024, 00:00

  • HTA18 Heading into the Unknown: How Will JCA Implementation Affect Global Launch Strategies?

    Jun 1, 2024, 00:00

  • RWD3 Review of the Use of Electronic Health Records for Advancing Schizophrenia Research in the UK

    Jun 1, 2024, 00:00

  • EE328 Direct Medical Costs in Patients with Non-Metastatic Castration Resistant Prostate Cancer (nmCRPC) in Colombia

    Jun 1, 2024, 00:00

  • MSR5 Leveraging Machine Learning To Understand Pet Owner Experiences of Feline Pruritus Through Social Media Listening

    Jun 1, 2024, 00:00

  • EPH226 Associations between Antimicrobial Susceptibility of Streptococcus Pneumoniae and Disease Severity Outcomes in Older Adults with Invasive Pneumococcal Disease in Sao Paulo, Brazil

    Jun 1, 2024, 00:00

  • EE307 Economic Evaluation of a Screening Programme for Diabetes, Hypertension and Hyperlipidaemia in Middle-Aged Adults in Hong Kong: A Simulation Analysis

    Jun 1, 2024, 00:00

  • EE14 Cost of Care Comparison of Elranatamab-bcmm and Teclistamab-cqyv in Adult Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • RWD158 Assessing RSV Vaccination Trends in the Context of Seasonal RSV Diagnoses Using Near Real-Time Administrative Claims

    Jun 1, 2024, 00:00

  • MT36 Assessment and Comparison of the Manual Steps Required to Perform Whole Blood Processing Using a Semi-Automated Method Versus a Fully Automated Method

    Jun 1, 2024, 00:00

  • CO144 Association of All-Cause and Cause-Specific Mortality with High-Risk NAFLD/NASH in US Adults, NHANES III (1988-1994) Linked to Mortality Data through 2019

    Jun 1, 2024, 00:00

  • RWD28 Adherence to Janus Kinase Inhibitors Among Older Adults with Rheumatoid Arthritis Initiating New Treatment

    Jun 1, 2024, 00:00

  • HPR100 Health Technologies Value Assessment Through the Lens of Health Equity; How Far From Being Incorporated Routinely? An Environmental Scan of Health Equity Frameworks and Policy Gaps

    Jun 1, 2024, 00:00

  • EE87 Time-Driven Activity Based Costing of Advanced Ovarian Cancer From the Perspective of a Brazilian Public Hospital

    Jun 1, 2024, 00:00

  • EPH42 Evaluating the Public Health Impact of Dengue Vaccination in Indonesia: A Dynamic Transmission Modeling Assessment amidst Uncertainties in the Implementation Strategies

    Jun 1, 2024, 00:00

  • Psychometric Evaluation of the Patient’s Knee Implant Performance Questionnaire

    Jun 1, 2024, 00:00

  • EPH107 Characteristics of the COVID-19 Epidemic in Three Hungarian Disctricts

    Jun 1, 2024, 00:00

  • CO13 A Claims Analysis To Characterize All-Cause Mortality in Patients With Generalized Pustular Psoriasis in the United States

    Jun 1, 2024, 00:00

  • MSR64 Using Large Language Models To Extract PD-L1 Testing Details From Electronic Health Records

    Jun 1, 2024, 00:00

  • EE156 Temporal Excess Hospital Costs of Complications in Chinese Patients With Type 2 Diabetes: Results from the Joint Asia Diabetes Evaluation (JADE) Register (2007-2018)

    Jun 1, 2024, 00:00

  • EE501 Estimating the Impact of Delayed Treatment for Major Depressive Disorder Using a Continuous-Time Patient-Level Simulation Model

    Jun 1, 2024, 00:00

  • EE528 Comparative Effectiveness Modeling of an Anti-Pd-1 Antibody Drug Intervention for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the U.S.

    Jun 1, 2024, 00:00

  • HPR38 Estimating the Outcome Disparities in BIPOC and Economically-Disadvantages Patients With Systemic Lupus Erythematosus (SLE)

    Jun 1, 2024, 00:00

  • PCR234 Patient and Oncologist Preferences for Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer (ALK+ aNSCLC) Tyrosine Kinase Inhibitors (TKIs) Treatments in the First Line (1L) Setting

    Jun 1, 2024, 00:00

  • HSD51 Evaluation of the Healthcare System Burden Associated With Intravenous Treatment for Paroxysmal Nocturnal Hemoglobinuria

    Jun 1, 2024, 00:00

  • EE164 A Systematic Review and Meta-Analysis of Economic Burden of Breast Cancer Among Adult Females: Based on the Perspective of Social Development Level and Progression of Disease

    Jun 1, 2024, 00:00

  • EPH123 Incorporating Social Determinants of Health Into Transmission Modeling of COVID-19 Vaccine in the US: A Scoping Review

    Jun 1, 2024, 00:00

  • MSR17 Leveraging Large Language Models (LLMs) for Classifying Peer Reviewed Publications for Literature Review

    Jun 1, 2024, 00:00

  • RWD146 Characterization of Chronic Kidney Disease Patients By eGFR Status Using Health Insurance Claims Linked to Lab Testing Data

    Jun 1, 2024, 00:00

  • MSR58 Comparing Predictive Models: Traditional Versus Modern Statistical Approaches for Economic Outcomes in Major Depressive Disorder

    Jun 1, 2024, 00:00

  • EE18 Burden of Illness for Adults With Chronic Inflammatory Demyelinating Polyneuropathy in the United States

    Jun 1, 2024, 00:00

  • CO118 Sickle Cell Disease Outcomes in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • MT23 The Changing Healthcare Landscape of Lumbar Spinal Fusion: Two-Year Claims Database Analysis

    Jun 1, 2024, 00:00

  • RWD183 Experience in Implementing Clinical Trial to Real-World Data (RWD) Linkage

    Jun 1, 2024, 00:00

  • RWD164 Evidence Gap Analysis of the Burden of Disease in Thyroid Eye Disease

    Jun 1, 2024, 00:00

  • HPR149 Americans' Views on Health Inequality in the United States: Results from a General Population Survey

    Jun 1, 2024, 00:00

  • HSD45 Effectiveness of Aseptic and Disinfection Measures in Dental Offices in Barranquilla, Colombia

    Jun 1, 2024, 00:00

  • EE333 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the U.S.: An Updated Analysis

    Jun 1, 2024, 00:00

  • EPH8 Comparison of Patient Identification Methodologies in Chronic Inflammatory Demyelinating Polyneuropathy Using United States Administrative Claims Data

    Jun 1, 2024, 00:00

  • CO55 Incidence of Adverse Events with Pembrolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Systematic Review of Literature

    Jun 1, 2024, 00:00

  • HSD57 Current Status of Off-Label IV Ketamine Utilization for Mood Disorders: A Nationwide Survey of Ketamine Clinics, Treatment Processes, and Provider Perceptions of Outcomes

    Jun 1, 2024, 00:00

  • CO115 Long-Term Post-Recurrence Survival (PRS) Outcomes for Stage IIB/C Melanoma Patients in Real-World (RW) Settings: Analyses from a Longitudinal Electronic Health Record Database in the United States

    Jun 1, 2024, 00:00

  • EPH176 Comparison of Superoxide Dismutase Activities (Mn-SOD AND Cu/Zn-SOD) in Patients Infected with Dengue Virus or Zika Virus

    Jun 1, 2024, 00:00

  • EE417 Healthcare Resource Use and Costs of Care in HR+/HER2- Metastatic Breast Cancer: A Retrospective US Claims Data Study

    Jun 1, 2024, 00:00

  • EE3 Cost Effectiveness Model on Four Preventive Treatment for Clostridioides Difficile Infection Recurrence From a US Payer Perspective

    Jun 1, 2024, 00:00

  • CO180 Newer Glucose-Lowering Drugs and Risk of Depression: A Meta-Analysis of Randomized Outcome Trials

    Jun 1, 2024, 00:00

  • HSD112 Product Entry Sequence and Priority of Follow-on Drug Use: A Case Study of Second-Generation Antipsychotics with Long-Acting Injections

    Jun 1, 2024, 00:00

  • The Patient and Caregiver Perspective for Healthcare Decision-Making

    Jun 1, 2024, 00:00

  • EPH120 Incidence, Prevalence and Clinical Characteristic of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study

    Jun 1, 2024, 00:00

  • HTA27 An Analysis of Manufacturer and Patient Engagement with Institute for Clinical and Economic Review Assessments

    Jun 1, 2024, 00:00

  • EE168 Avoidable Costs in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated with Darolutamide

    Jun 1, 2024, 00:00

  • RWD143 Update of Our Review of Real-World Evidence in HTA Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan

    Jun 1, 2024, 00:00

  • Modeling for HTA

    Jun 1, 2024, 00:00

  • HPR141 Model Analysis on Budget Impact and Patients’ Burden of National Price-Negotiated Drugs and Different Reimbursement Payment Modes in China: Hyperkalemia As an Example

    Jun 1, 2024, 00:00

  • EE61 Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Mexican Adults Population

    Jun 1, 2024, 00:00

  • RWD129 Trends in GLP-1 Receptor Agonist Dispensing Among US Patients Without Type 2 Diabetes Using Real World Data

    Jun 1, 2024, 00:00

  • EPH63 Epidemiological Disease Burden of Female Infertility of Other Origin Based on Routinely Collected Health Insurance Claims Data between 2010-2019

    Jun 1, 2024, 00:00

  • PCR199 Advancing Patient-Centered Outcomes Research for Rare Diseases: A Mixed-Methods Approach

    Jun 1, 2024, 00:00

  • SA39 Exploring the Landscape of Genetically Modified Natural Killer Cell (GMNKC) Therapies: A Review of Clinical Trials Indexed on ClinicalTrials.gov

    Jun 1, 2024, 00:00

  • EE340 Real-World Healthcare Resource Utilization and Costs of Patients with Alzheimer’s Disease By Stage: A Retrospective Observational Study

    Jun 1, 2024, 00:00

  • RWD154 Evaluation of Mortality Data Sources for Use in Real-Word Data Analyses

    Jun 1, 2024, 00:00

  • EPH19 Opioid-Related Overdose Death Rates in the US From 2005 to 2021

    Jun 1, 2024, 00:00

  • P60 Evaluating Dynamic Treatment Using a Target Trial: The Real-World Effectiveness of Adding Oral Selexipag to a Double Oral Therapy for the Treatment of Patients With Pulmonary Arterial Hypertension

    Jun 1, 2024, 00:00

  • RWD144 Predictive Risk Score for Nonalcoholic Steatohepatitis (NASH) Among Patients in the Department of Defense Population

    Jun 1, 2024, 00:00

  • EE510 Navigating Economics of Telehealth in Oncology

    Jun 1, 2024, 00:00

  • HTA76 Insights into Health Technology Reassessment in Fran A Comprehensive Analysis of Key Outcomes and Manufacturers Engagement (2022-2023)

    Jun 1, 2024, 00:00

  • CO146 Treatment Use and Overall Survival of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study

    Jun 1, 2024, 00:00

  • CO84 Racial/Ethnic Differences in Healthcare Resource Utilization Among Patients With Amyotrophic Lateral Sclerosis in Texas

    Jun 1, 2024, 00:00

  • PT44 Prevalence of Comorbidities and Hospitalization in the 65 and over SLE (SYSTEMIC LUPUS ERYTHEMATOSUS) Patient Population: A Comparative Analysis of the FORWARD Lupus Registry and Medicare Data in the US (2017-2021)

    Jun 1, 2024, 00:00

  • PT20 Gleaning Novel Insights from Real World Data: A Machine-Learning Guided Analytical Framework

    Jun 1, 2024, 00:00

  • EE514 Private Hospital Acute Stroke Care Costs: Patient's Viewpoint

    Jun 1, 2024, 00:00

  • PCR151 Understanding the Patient Perspectives of Post-Discharge Care and Impact of Treatment in the First Year Post-Acute Myocardial Infarction

    Jun 1, 2024, 00:00

  • CO104 Clinical Outcomes of Second-Line and Beyond (2L+) Treatments (TXS) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • MSR52 Assessing the Representativeness of Provider Encounter Data From a Large Claims Database on Adults With Major Depression

    Jun 1, 2024, 00:00

  • EPH149 Regional Dynamics and Prevalence of COVID-19 Variants in US Health and Human Services Regions

    Jun 1, 2024, 00:00

  • HSD48 US Infusion Center Capacity to Accommodate Anti-Amyloid Treatments for Alzheimer’s Disease: A Quantitative Survey

    Jun 1, 2024, 00:00

  • EE33 Cost-Effectiveness of Aducanumab, Lecanemab, and Donanemab for Early Alzheimer Disease in the US

    Jun 1, 2024, 00:00

  • HSD31 Analyzing Factors Affecting Length of Emergency Department Stay in Patients With Hemophilia

    Jun 1, 2024, 00:00

  • EE22 COPD-Related Healthcare Resource Utilization Before and After Initiating Inhaled Corticosteroid-Containing Maintenance Regimens: Real World Claims Data

    Jun 1, 2024, 00:00

  • CO124 Association Between Quality of Life and Viral Load Among People With HIV in the Current Antiretroviral Era

    Jun 1, 2024, 00:00

  • EPH183 The Association Between the Minority Health Social Vulnerability Index and Pneumococcal Disease Incidence Among Medicare Beneficiaries (2016-2019)

    Jun 1, 2024, 00:00

  • CO41 Comparative Effectiveness of Glucagon-like Peptide 1 Agonists Vs Dipeptidyl Peptidase 4 Inhibitors on Liver Outcomes in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Fatty Liver Disease

    Jun 1, 2024, 00:00

  • EE296 A United States Payer Budget Impact Analysis of Myocardial Perfusion Imaging Modalities Positron Emission Tomography with Flurpiridaz Compared to Single Photon Emission Computed Tomography in Coronary Artery Disease Diagnosis

    Jun 1, 2024, 00:00

  • Study Approaches

    Jun 1, 2024, 00:00

  • PCR62 Household Costs for Home, Vehicle, and Medical Equipment Expenditures to Accommodate Functional Impairments for Individuals with Duchenne Muscular Dystrophy

    Jun 1, 2024, 00:00

  • PCR49 Mapping and Linking between the EQ-5D-5L and the PROPr in the United States

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • MSR30 Use of Natural Language Processing to Augment Real-World Data (RWD) and Identify Eligible Patients at Scale for Oncology Studies

    Jun 1, 2024, 00:00

  • RWD54 Comparative Analysis of Different Methods of Disease Progression Data Capture in Patients With Metastatic Castration-Resistant Prostate Cancer

    Jun 1, 2024, 00:00

  • HPR77 CMS Coverage Lift on PET Beta Amyloid Imaging Impact on mAb Treatment and Beneficiary Out-Of-Pocket Spending

    Jun 1, 2024, 00:00

  • EPH134 Difference in E-Cigarette Use Prevalence in Adolescents between 2019 and 2021 in Georgia, United States

    Jun 1, 2024, 00:00

  • PCR30 An Investigation of Patient Journey Assessment in Rare Disease

    Jun 1, 2024, 00:00

  • EE70 The Cost of Chronic Lung Allograft Dysfunction (CLAD) in Lung Transplant (LTx) Recipients By Stage 0-4: A Claims Database Analysis

    Jun 1, 2024, 00:00

  • MSR18 Improving the Performance of Generative AI to Achieve 100% Accuracy in Data Extraction

    Jun 1, 2024, 00:00

  • RWD137 Automated Non-Interventional Research Protocol Generation: A Case Study in Melanoma

    Jun 1, 2024, 00:00

  • PCR229 Development of the ADHD Treatment Satisfaction Questionnaire (ATSQ) for Use with Children, Adolescents, and Their Caregivers

    Jun 1, 2024, 00:00

  • SA37 Costs and Quality of Life in Clinical Trials of Heart Failure in the US

    Jun 1, 2024, 00:00

  • MSR45 Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients With Atrial Fibrillation and Cancer

    Jun 1, 2024, 00:00

  • SA72 Health System As an Adaptative Complex System for Open Innovation

    Jun 1, 2024, 00:00

  • EE355 Can Large Language Models Generate Conceptual Health Economic Models?

    Jun 1, 2024, 00:00

  • EE115 Clinical and Economic Impact of Glucagon-like Peptide-1 Agonists in Patients with Obstructive Sleep Apnea: An Exploratory Analysis

    Jun 1, 2024, 00:00

  • MSR105 Proportional Randomization Method to Identify Index Line of Therapy in Externally Controlled Trials

    Jun 1, 2024, 00:00

  • CO8 Leading Predictors of Incident Hypertension Among Patients with Cancer in Community Health Centers: A Machine Learning Approach with Shapley Additive Explanations Using Electronic Health Records

    Jun 1, 2024, 00:00

  • PCR245 Patient Characteristics and Improved Outcomes With Greater Adherence to Acthar® Gel in Nephrotic Syndrome

    Jun 1, 2024, 00:00

  • EE279 Cost-Effectiveness Analysis of Biosimilars and Novel Biologics for Patients With Moderate-to-Severe Psoriasis

    Jun 1, 2024, 00:00

  • RWD160 An Episode-Based Analysis in a Medicare Advantage Population to Identify the Cost Impact of Virtual-First Care for Common Acute Conditions

    Jun 1, 2024, 00:00

  • HPR91 Public Sector Replacement of Privately Funded Pharmaceutical RD: Cost and Efficiency Considerations

    Jun 1, 2024, 00:00

  • PT7 Engaging Patients With Rare Disease in Identifying Meaningful Approaches to Integrate Patient-Centered Outcomes in Comparative Effectiveness Research and Value Assessment

    Jun 1, 2024, 00:00

  • PCR225 The Caregiver Perspective on Dry Age-Related Macular Degeneration: A Qualitative Interview Study

    Jun 1, 2024, 00:00

  • EE160 Evidence to Inform Forecasts of Biopharmaceutical Policy Impact

    Jun 1, 2024, 00:00

  • SA7 Outcomes With Novel Therapies for Relapsed or Refractory Follicular Lymphoma: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • EPH21 Burden of Unresectable/Metastatic Melanoma(u-mMel) and Advanced/Metastatic Colorectal Cancer(mCRC), and Their Associated BRAF-mutations in Four LATAM Countries: A Targeted Literature Review of Epidemiological and Economic Evidence

    Jun 1, 2024, 00:00

  • PCR171 Measuring Disease and Treatment-Related Symptoms and HRQoL Impacts in Patients With High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) Using the EORTC Qlq-C30 and NMIBC-24: Qualitative Literature Review and Gap Analysis

    Jun 1, 2024, 00:00

  • EE258 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) for High-Risk Patients in Chile

    Jun 1, 2024, 00:00

  • MSR83 Predicting Optimal Treatment Regimen to Improve Outcomes of Patients With CLL/SLL Using Random Survival Forest

    Jun 1, 2024, 00:00

  • RWD26 Tokenization-Linked Social Determinants of Health (SDoH) Data: A Gateway to Enhanced Understanding of Rare Disease Clinical Trial Populations

    Jun 1, 2024, 00:00

  • RWD63 Utilizing AI/ML for Insight Into the Transition Factors From Traditional (Non-Nano Delivery) to Nano Drug Delivery of Paclitaxel in Breast Cancer Patients

    Jun 1, 2024, 00:00

  • HSD120 Effectiveness of Pharmacist-Led Interventions on Medication Use and Related Health Outcomes in Patients With Alzheimer's Disease and Related Dementias: A Systematic Review

    Jun 1, 2024, 00:00

  • HSD99 Impact of Pink October in Mammographic Screening in a Health Care Plan in Brazil

    Jun 1, 2024, 00:00

  • EE392 Number Needed to Treat (NNT) Comparing Sacituzumab Govitecan and Single-Agent Chemotherapy in Relapsed or Refractory Metastatic Triple-Negative Breast Cancer

    Jun 1, 2024, 00:00

  • SA62 Treatment Patterns Following First Line CDK4/6 Inhibitor Progression in HR+, HER2- Metastatic Breast Cancer

    Jun 1, 2024, 00:00

  • RWD69 Utilization of Current Procedural Terminology Codes in Pharmacists' Services Using Medicare Data Claims

    Jun 1, 2024, 00:00

  • CO106 Clinical Outcomes of Patients in the Intensive Care Unit with Infections Caused By Multiresistant Gram-Negative Bacteria in Colombian Patients

    Jun 1, 2024, 00:00

  • HSD35 Real-World Treatment Patterns and Treatment Sequences in the Metastatic Castration-Resistant Prostate Cancer Settings across Europe

    Jun 1, 2024, 00:00

  • CO105 Disease Burden and Treatment in Patients with Essential Tremor in the United States: Real-World Evidence from a Cross-Sectional Survey of Physicians and Patients

    Jun 1, 2024, 00:00

  • HPR21 Healthcare Expenditure and Its Association with Under Five Mortality: A Cross-Country Analysis in the Eastern Mediterranean Region

    Jun 1, 2024, 00:00

  • HPR86 The Impact of Mandated Prescription Drug Monitoring Program Registration on Prescription Opioid-Related Mortality in California

    Jun 1, 2024, 00:00

  • EE172 Quantifying the Relationship between Time to Diagnosis and Potential System Level Burden in Obstructive Hypertrophic Cardiomyopathy (HCM)

    Jun 1, 2024, 00:00

  • CO156 Indirect Treatment Comparison (ITC) of Cabotegravir Long Acting (CAB-LA) for Pre-Exposure Prophylaxis (PREP) Versus No Prep for HIV Prevention

    Jun 1, 2024, 00:00

  • EE79 Real-World Clinical and Economic Burden of Primary Biliary Cholangitis in the United States

    Jun 1, 2024, 00:00

  • HPR44 Implications of Regulatory Telemedicine Prescribing Flexibilities on Patients With Opioid Use Disorder

    Jun 1, 2024, 00:00

  • RWD77 Time to Reimbursement in Kazakhstan for Novel Biologic Medicines Approved during the Period 2013-2022

    Jun 1, 2024, 00:00

  • PCR89 Impact of Dosing and Administration on HRQoL Among People With Hemophilia: A Time Trade-Off Study Including 2.250 Respondents in the UK, Canada and the US

    Jun 1, 2024, 00:00

  • HPR113 Equity in Antenatal Care Quality: An Analysis of 11.382 Cases from 23 Municipalities in Colombia

    Jun 1, 2024, 00:00

  • EPH224 Effectiveness of COVID-19 Vaccines in Colombia: Findings from Two Highly Specialized Healthcare Centers

    Jun 1, 2024, 00:00

  • HSD29 Predicting Psoriasis Area and Severity Index From Physician Global Assessment and Body Surface Area in the Real-World Dermatology Setting

    Jun 1, 2024, 00:00

  • MSR47 Assessing the Impact of the Prior Distribution for the Within-Study Correlation in Bivariate Network Meta-Analysis: A Case Study in Relapsed/Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • PCR238 Estimating Health State Utilities (HSUS) for Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD) in the United States

    Jun 1, 2024, 00:00

  • PCR31 Crosscultural Adaptation of the Hungarian Version of Stroke Impact (SIS)

    Jun 1, 2024, 00:00

  • CO53 Real-World Evidence of the Effectiveness of Inhaled Corticosteroid-Containing Therapies in Reducing Exacerbations and Medical Costs in COPD

    Jun 1, 2024, 00:00

  • EPH38 Antimicrobial Susceptibility of Klebsiella Pneumoniae Clinical Isolates From the Lower Respiratory Tract Infection During the COVID-19 Pandemic in Brazil (SMART 2020-2021)

    Jun 1, 2024, 00:00

  • HTA23 Caregiver Health-Related Quality of Life in National Institute for Health and Care (NICE) Appraisals: From Inception to 2023

    Jun 1, 2024, 00:00

  • PCR92 Association of Rheumatoid Arthritis (RA) Patient Characteristics and Perceived Treatment Satisfaction, RA Impact on Life, and Task Difficulty with Promis Measures’ Physical Functioning and Upper Extremity Scores

    Jun 1, 2024, 00:00

  • P6 The Effect of Formulary Restrictions on the Disease Outcomes Among Medicare Beneficiaries With Multiple Sclerosis in the United States

    Jun 1, 2024, 00:00

  • EE479 Adverse Event Costs Associated With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States, Italy, Portugal, and Spain

    Jun 1, 2024, 00:00

  • P56 Extraction of Inflammatory Bowel Disease Severity Scores from Unstructured Clinical Notes Using a Retriever-Reader Architecture

    Jun 1, 2024, 00:00

  • SA10 The Safety and Effectiveness of Intraoperative Radiotherapy With Low-Energy X-Ray for Breast Cancer: A Systematic Review

    Jun 1, 2024, 00:00

  • HTA57 Uptake of Early Health Technology Assessment in the United States (US): A Literature Review of Empirical Studies

    Jun 1, 2024, 00:00

  • EE113 Impact of Type 1 Diabetes and Severe Hypoglycemia on Productivity and Out-of-Pocket Costs of Adult Continuous Glucose Monitor Users: Results From a Cross-Sectional Survey in the United States

    Jun 1, 2024, 00:00

  • RWD150 Tirzepatide and Weight Reduction Among Individuals without Evidence of Type 2 Diabetes: Descriptive Results from Optum’s De-Identified Market Clarity Data

    Jun 1, 2024, 00:00

  • MSR100 Prediction Models for Cardiotoxicity Induced By Anticancer Drug in Women with Breast Cancer

    Jun 1, 2024, 00:00

  • EPH202 Assessing Trends in Utilization and Off-Label Prescribing for Ozempic, a Glucagon-like Peptide Receptor Agonist

    Jun 1, 2024, 00:00

  • SA68 Assessment of Real-World Data Sources and a Hybrid Approach in Real-World Evidence Generation Using Unharmonized Data Sources

    Jun 1, 2024, 00:00

  • SA22 Does the Use of Investigator-Choice Comparator Arms in Oncology Clinical Trials Influence Payer Assessments Outcomes?

    Jun 1, 2024, 00:00

  • EPH241 Benzodiazepines and Adrenergic beta2-Agonists: A Synergistic Impact on Health-Related Quality of Life Among Older Adults with Prostate Cancer

    Jun 1, 2024, 00:00

  • EPH184 Patient Journey of Head Neck Squamous Cell Cancer in Oncology Centers in Colombia

    Jun 1, 2024, 00:00

  • PCR192 Using Linked Claims and EHR Real-World Data to Determine Medication Adherence Among Common Therapeutic Areas of Chronic Disease

    Jun 1, 2024, 00:00

  • CO99 Validation of Overall Survival (OS) Extrapolations Using 5-Year Follow-up Data From the Keynote-177 MSI-H/dMMR Metastatic Colorectal Cancer (mCRC) Study

    Jun 1, 2024, 00:00

  • EE133 Burden of Illness for Adults Living With Primary Chronic Immune Thrombocytopenia in the United States

    Jun 1, 2024, 00:00

  • EE357 Using a Computer Vision-Based System for Reading Skin Prick Test Results: A Cost-Minimisation Analysis

    Jun 1, 2024, 00:00

  • MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare

    Jun 1, 2024, 00:00

  • MT48 Assessment of a Patient-Centric Web Application Tool for Potential Adverse Events of Oral Corticosteroids

    Jun 1, 2024, 00:00

  • EPH11 Determinants of Mammography Screening Participation– A Cross-Sectional Analysis of the Hungarian Sample

    Jun 1, 2024, 00:00

  • HSD107 Out-of-Pocket Health Care Spending Among Medicare Beneficiaries by Sex, Age, and Race/Ethnicity

    Jun 1, 2024, 00:00

  • EE274 Cost-Effectiveness Analysis of Large-Scale Screening for Celiac Disease in the Pediatric Population

    Jun 1, 2024, 00:00

  • CO161 Adherence and Persistence To Oral Targeted Therapies for Non-Small-Cell Lung Cancer and Association With Survival Outcomes

    Jun 1, 2024, 00:00

  • EE85 Sources of Increased Expenditures for Young Children with Autism Spectrum Disorder Diagnoses in Employer-Sponsored Plans, 2016–2021

    Jun 1, 2024, 00:00

  • EE64 Treatment-Related Costs of Ponatinib and Asciminib in Adults Patients with T315I-Positive Chronic Phase Chronic Myeloid Leukemia with Resistance or Intolerance to at Least Two Prior Kinase Inhibitors in the United States

    Jun 1, 2024, 00:00

  • MSR57 Transforming Systematic Literature Reviews: Unleashing the Potential of GPT-4: A Cutting-Edge Large Language Model, to Elevate Research Synthesis

    Jun 1, 2024, 00:00

  • MSR34 Diversity in Clinical Trials: Life Science Initiatives and Challenges in Light of the FDA’s Latest Guidance

    Jun 1, 2024, 00:00

  • EE448 A Recent Adoption of Cost-Effectiveness Thresholds in Brazil and Its Repercussions

    Jun 1, 2024, 00:00

  • EE359 Economic Burden of Managing Acute and Chronic Pain in the United States: National Estimates from 2022 Data

    Jun 1, 2024, 00:00

  • CO108 The Effect of Approved Anti-Obesity Medications in Patients With Alcohol and Substance Abuse Disorder

    Jun 1, 2024, 00:00

  • EPH163 Off-Label Use of Semaglutide in the United States: Increasing Prevalence, Variability in Prescribing Provider Specialty, and Patient Characteristics

    Jun 1, 2024, 00:00

  • EPH1 High Throughput Screening for Roflumilast Adverse Effects in Real-World Settings: A Sequence Symmetry Analysis

    Jun 1, 2024, 00:00

  • EE165 A Cost-Consequence Analysis of Ponatinib Versus Imatinib in Patients with Newly Diagnosed Philadelphia-Positive Acute Lymphoblastic Leukemia in the United States

    Jun 1, 2024, 00:00

  • HPR105 Breadth of Patient and Stakeholder Input in CMS's Drug Price Negotiation Program: A Content Analysis of the 2023 Patient-Focused Listening Sessions

    Jun 1, 2024, 00:00

  • CO193 Real-World Retrospective Analysis Comparing a Bilayered Living Cellular Construct and a Fetal Bovine Collagen Dressing for Use in Venous Leg Ulcers

    Jun 1, 2024, 00:00

  • RWD118 Implementation and Validation of a Prioritization Logic to Identify the Best Available Race/Ethnicity Information for Members in Commercial Plans

    Jun 1, 2024, 00:00

  • EPH39 A Targeted Literature Review (TLR) of Clinical, Humanistic, and Economic Burden of Alzheimer’s Disease (AD) in the United States (US)

    Jun 1, 2024, 00:00

  • MSR53 Estimands in EQ-5D-5L: How to Deal with the “Worse Than Death” and the Intercurrent Events of “Death”

    Jun 1, 2024, 00:00

  • RWD100 Assessing the Representativeness of Real-World Claims Databases

    Jun 1, 2024, 00:00

  • CO2 Association Between Classes of Antidiabetic Medications and Their Potential Risk or Protective Effects on Cancer: A Systematic Review and Network Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR114 Young People’s Barriers and Facilitators of Engagement With Web-Based Mental Health Interventions for Anxiety and Depression: A Qualitative Study

    Jun 1, 2024, 00:00

  • HTA63 The Role and Implementation of Patient and Public Involvement in Health Technology Assessment: A Systematic Search and Implications for Japan

    Jun 1, 2024, 00:00

  • HSD41 Disparities by Gender, Race and Geography Exist in Whether Patients Receive a Confirmatory Celiac Disease Endoscopy and Biopsy After Screening Positive

    Jun 1, 2024, 00:00

  • PT45 Patient Perspective in Endometriosis and Clinical Trial Barriers

    Jun 1, 2024, 00:00

  • CO209 Comorbidities in Myasthenia Gravis in the US National Veterans Affairs Health Network.

    Jun 1, 2024, 00:00

  • CO160 Relationship between Loss of Ambulation (LoA), Disease Burden, and Physical Functioning Among Boys with Duchenne Muscular Dystrophy (DMD)

    Jun 1, 2024, 00:00

  • RWD145 Healthcare Resource Utilization (HCRU) and Costs Among Previously-Treated Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Retrospective Analysis of SEER-Medicare Linked Claims

    Jun 1, 2024, 00:00

  • MSR90 Incorporating Patient Preferences Into Mathematical and Statistical Models in Health Economics: A Taxonomy of Approaches

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • EE16 Economic Analysis of the Impact of Delandistrogene Moxeparvovec Gene Therapy on Work Opportunity in Caregivers of Individuals with Duchenne Muscular Dystrophy

    Jun 1, 2024, 00:00

  • EPH111 Diabetes' Prevalence by Gender, Age, and Race in the United States (Trends Between 2005 and 2019)

    Jun 1, 2024, 00:00

  • RWD187 The Use of a Large Epidemiological Surveillance Dataset (SIVEP-Gripe) for the Generation of Scientific Evidence in Brazil on COVID-19: A Literature Review

    Jun 1, 2024, 00:00

  • PT35 Cost-Effectiveness Analysis of Nivolumab Versus Docetaxel for the Treatment of Advanced Nonsquamous NSCLC Including PD-L1 Testing in the United States

    Jun 1, 2024, 00:00

  • EPH10 Serotype Distribution Among Streptococcus Pneumoniae Isolates in Puerto Rico (PNEUMOSER STUDY)

    Jun 1, 2024, 00:00

  • PCR233 Adherence and Persistence of Oral Anticoagulants for Treatment of Atrial Fibrillation across Stroke and Bleeding Risk Strata

    Jun 1, 2024, 00:00

  • EPH171 A Qualitative Survey Analysis for Understanding COVID-19 Vaccine Hesitancy in the United States

    Jun 1, 2024, 00:00

  • EPH22 Epidemiology and Treatment Patterns of Colombian Patients With Metastatic Colorectal

    Jun 1, 2024, 00:00

  • EE457 Economic Burden Impact of Thyroid Eye Disease in the United Arab Emirates

    Jun 1, 2024, 00:00

  • CO151 A Preliminary Analysis of Oral Edaravone-Treated Patients With Amyotrophic Lateral Sclerosis Enrolled in a US-Based Administrative Claims Database

    Jun 1, 2024, 00:00

  • HTA12 Investigating the Influence of Therapy-Related Factors on Reimbursement Success: A Multi-Country Analysis

    Jun 1, 2024, 00:00

  • P4 Is Later Diagnosis of Rare Diseases Associated with Higher Medical Costs? Real-World Evidence for Duchenne/Becker Muscular Dystrophy

    Jun 1, 2024, 00:00

  • EPH158 Using Data to Develop Precision Medicine Approaches to Public Health Initiatives

    Jun 1, 2024, 00:00

  • PT14 The Effectiveness of Bisphosphonates on Recurrent Osteoporotic Fractures Post-Denosumab Discontinuation Using Causal Machine Learning

    Jun 1, 2024, 00:00

  • HSD30 Incidence of Platinum-Resistant, Stage III/IV Ovarian Cancer Patients in the US: A Mixed Source Estimation Approach

    Jun 1, 2024, 00:00

  • HPR76 Disparities in NMOSD Hospitalization Outcomes: A 5-Year Analysis of the Impact of Sociodemographic Factors on Healthcare Utilization and Charges

    Jun 1, 2024, 00:00

  • EE284 Cost-Effectiveness Analysis of Larotrectinib and Entrectinib for Adult Patients with NTRK Gene Fusion-Positive Breast Cancer

    Jun 1, 2024, 00:00

  • Economic Evaluation

    Jun 1, 2024, 00:00

  • PCR63 Public Deliberation on Health Gain Measures

    Jun 1, 2024, 00:00

  • PCR167 Targeted Literature Review to Understand the Patient Experience of Essential Thrombocythemia and to Evaluate Existing Clinical Outcome Assessment Measures

    Jun 1, 2024, 00:00

  • EE440 Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in Adults Aged 50-59 Years With Cardiopulmonary Diseases in the United States

    Jun 1, 2024, 00:00

  • MSR78 The Impact of Variable Days of Coverage on Estimating Diagnosis and Treatment Prevalence From Administrative Claims Data

    Jun 1, 2024, 00:00

  • SA70 Identifying Early Disease Progression in Tricuspid Regurgitation When Echocardiographic Imaging Data Is Unavailable

    Jun 1, 2024, 00:00

  • EE144 Chimerism Testing for Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Cost-Utility Analysis

    Jun 1, 2024, 00:00

  • MSR63 Improving Efficiency in Analysis of Real-World Data with an Automated Machine Learning Tool

    Jun 1, 2024, 00:00

  • SA40 A Targeted Literature Review of Economic Evaluations, Health-Related Quality of Life, Healthcare Resource Use, and Economic Outcomes Associated With Giant Cell Arteritis

    Jun 1, 2024, 00:00

  • EE245 Budget Impact of Inotersen for the Treatment of Stage I or II Polyneuropathy in Adult Patients With Hereditary Transthyretin Amyloidosis (hATTR) in Public Health Mexico

    Jun 1, 2024, 00:00

  • RWD90 The Association Between Developing ADRD and Having a History of Depression: A Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • EE462 Healthcare Utilization in Non-Alcoholic Steatohepatitis (NASH) Patients with Elevated Nafld Activity Score (NAS): Impact of Fibrosis Levels

    Jun 1, 2024, 00:00

  • RWD85 An Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

    Jun 1, 2024, 00:00

  • EE106 Cost-Effectiveness Analysis of Belimumab for the Treatment of Adults With Active Lupus Nephritis in China

    Jun 1, 2024, 00:00

  • EPH96 Descriptive Statistics and Disease Prevalence from an Electronic Health Record Data Collective across 30+ US Health Systems

    Jun 1, 2024, 00:00

  • CO179 The Association Between Social Determinants of Health, COVID-19, and Incidence of De Novo Depression Following Traumatic Brain Injury

    Jun 1, 2024, 00:00

  • EE187 Remdesivir Reduced Healthcare Resource Utilization in Patients Hospitalized With COVID-19 During the Omicron-Dominant Period

    Jun 1, 2024, 00:00

  • RWD99 Healthcare Costs of Cancer by Clinical Stage and Cost Component in a Private Health Plan in Brazil (Real World Data)

    Jun 1, 2024, 00:00

  • EE263 Characterization of End-Stage Kidney Disease Patients With and Without Autosomal Dominant Polycystic Kidney Disease and Receiving Kidney Transplantation in the United States

    Jun 1, 2024, 00:00

  • EE366 Healthcare Costs Comparison of Dupilumab Vs. Omalizumab, Benralizumab and Mepolizumab in Patients with Moderate-to-Severe Asthma: A US Payer Perspective

    Jun 1, 2024, 00:00

  • RWD162 The Development of a National Standardset for Bariatric Surgery Followed By a Digital Solution to Scale It at a National Level in Portugal

    Jun 1, 2024, 00:00

  • EE272 Treating Patients With Non-Valvular Atrial Fibrillation With Apixaban Provides Substantial Consumer Value and Surplus Compared With Warfarin and Rivaroxaban

    Jun 1, 2024, 00:00

  • PCR76 Exploring the Content and Psychometric Validity of Clinical Outcome Assessments in Renal Cell Carcinoma Versus the Patient Reported Symptoms and Impacts

    Jun 1, 2024, 00:00

  • CO141 Situation Report: Health Status of Hungarian Ambulance Workers in the COVID Era

    Jun 1, 2024, 00:00

  • PCR255 Evaluating the Suitability of Patients As Proxies for Caregivers’ HR-QoL Assessments

    Jun 1, 2024, 00:00

  • EE234 Quality of Life and Burden of Epilepsy Patients in United States: A Comparative Study of Matched Case-Control Based on Medical Expenditure Panel Survey (MEPS), 2017-2021

    Jun 1, 2024, 00:00

  • RWD74 Sex and Racial/Ethnic Disparities in Cardiovascular Disease Mortality Risk Among United States Cancer Patients

    Jun 1, 2024, 00:00

  • HPR123 Impact of Mandated Use of the Texas Prescription Monitorsing Program on Carisoprodol Dispensing in Texas

    Jun 1, 2024, 00:00

  • MSR24 A Case Study Using Keynote-010 to Compare and Evaluate Long-Term Survival Estimates from Two Classes of Piecewise Models

    Jun 1, 2024, 00:00

  • EPH20 Trends in New Prescriptions for Opioids, Non-Opioids, and Opioid Antagonists in the United States, 2019 - 2023

    Jun 1, 2024, 00:00

  • MSR60 Addressing the Overlooked Inquiry in Feasibility Assessment of Network Meta-Analysis through the Covariate-Optimized Spatial Method for Integrated Clustering (COSMIC)

    Jun 1, 2024, 00:00

  • RWD5 A Novel Predictive Model for Agitation in Alzheimer’s Dementia Using Administrative Claims Data

    Jun 1, 2024, 00:00

  • CO73 Clinical Significance of KL-6 Biomarker in the Development of Connective Tissue Disease-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • EE123 Cost-Effectiveness of the Brexu-Cel in Relapsed/Refractory Mantle Cell Lymphoma and B-Cell Acute Lymphoblastic Leukemia: A Systematic Review

    Jun 1, 2024, 00:00

  • EPH161 Estimation of the Size of the Eligible Population in the United States for Resmetirom: A Novel Investigational Therapy for NASH

    Jun 1, 2024, 00:00

  • EPH178 Representing Thyroid Cancer Epidemiology in the US Over Time: A Microsimulation Modeling Approach Incorporating Temporal Differences in Thyroid Ultrasound Utilization by Sex and Age

    Jun 1, 2024, 00:00

  • PCR218 Gender Is Not Binary: An Online Survey To Improve Inclusivity in Sex and Gender Demographic Questions

    Jun 1, 2024, 00:00

  • HPR74 Challenges Encountered When Using Required Machine-Readable Files From the 2022 Transparency in Coverage Rule: A Blue Cross and Blue Shield of Louisiana Case Study

    Jun 1, 2024, 00:00

  • SA63 Comparative Analysis of Recurrence and Healthcare Expenditures After Primary Inguinal Hernia Repair Using Robotic-Assisted, Laparoscopic, and Open Surgical Approaches

    Jun 1, 2024, 00:00

  • PCR56 Are Limitations in Physical Function Relevant and Important Concepts To Assess in Patients on Antithrombotic Therapy for Cardiovascular Conditions?

    Jun 1, 2024, 00:00

  • PCR211 Health-Related Quality of Life in Adult Patients With Glaucoma, With or Without Visual Impairment in the US: Analysis of National Data From 2017 to 2021

    Jun 1, 2024, 00:00

  • EPH69 Uptake of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among United States (US) Adults Following 2022 Update to Recommendations

    Jun 1, 2024, 00:00

  • HPR71 Successfully Remaining in Community for Home Health Care Patients With Alzheimer's Disease and Related Dementia: The Role of Living Arrangements and Rural Living

    Jun 1, 2024, 00:00

  • EE301 Economic Burden of Disease Recurrence in Elderly Patients With High-Risk Endometrial Cancer (HR-EC) Receiving Adjuvant Therapy (AT)

    Jun 1, 2024, 00:00

  • Disclosure Information

    Jun 1, 2024, 00:00

  • EE316 Economic Burden of Fabry Disease in Colombia

    Jun 1, 2024, 00:00

  • Methodological Statistical Research

    Jun 1, 2024, 00:00

  • RWD105 The Clinical and Economic Burden of Woman with Endometriosis (EM)

    Jun 1, 2024, 00:00

  • CO187 Acute Pancreatitis Risk Associated with Glucagon-Like Peptide-1 Receptor Agonists Used for Weight Loss: A Retrospective Cohort Study in the United States

    Jun 1, 2024, 00:00

  • RWD36 Time to Reimbursement in Kazakhstan for Novel Cancer Medicines Approved during the Period 2013-2022

    Jun 1, 2024, 00:00

  • CO168 Association between Initial Propranolol Dose and Blood Pressure Control in 48 to 72 Hours Among Preterm Infants with Hypertension

    Jun 1, 2024, 00:00

  • MT4 The Trend, Outcomes, and Resources Utilization of Surgical Staplers Used in Patients Treated with Robotic Gastric Sleeve Procedures

    Jun 1, 2024, 00:00

  • PCR228 Healthcare Provider Preferences for Attributes of Influenza Vaccines in the United States: Results From a Discrete-Choice Experiment Study

    Jun 1, 2024, 00:00

  • HPR40 Do State Direct Access Laws to Physical Therapy Influence Healthcare Utilization and Costs Among Medicare Patients With Atraumatic Rotator Cuff Tears? An Instrumental Variable Approach

    Jun 1, 2024, 00:00

  • SA46 Are We Dealing With Heterogeneity in Network Meta-Analysis Appropriately? A Review of NICE Submissions

    Jun 1, 2024, 00:00

  • HPR30 Variation in per Beneficiary Prescription Utilization and Spending By Race/Ethnicity in Medicare and Medicaid Insurance Claims

    Jun 1, 2024, 00:00

  • MSR36 Current Applications of Machine Learning for Causal Inference in Healthcare Research Using Observational Data

    Jun 1, 2024, 00:00

  • CO11 Captopril Response Association With Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphisms in Mexican Indigenous

    Jun 1, 2024, 00:00

  • EE152 Cost-Effectiveness Analysis of Infliximab Versus Cyclosporine in Steroid-Refractory Acute Severe Ulcerative Colitis

    Jun 1, 2024, 00:00

  • MSR3 Cough, Dyspnea, Chest Pain or a Composite? Analysis of Key Symptoms in Metastatic Non-Small Cell Lung Cancer (mNSCLC) Clinical Trials

    Jun 1, 2024, 00:00

  • HSD113 Treatment Patterns, Comorbidities, Healthcare Resource Utilization and Related Costs of Dermatomyositis and Polymyositis in the United States: A Cohort Study in the Merative™ MarketScan® Database

    Jun 1, 2024, 00:00

  • PCR149 Buprenorphine Adherence Trajectories, Persistence, and Healthcare Expenditures Among Commercially Insured Patients With Opioid Use Disorder

    Jun 1, 2024, 00:00

  • PCR153 Psychometric Evaluation of the Allergan Satisfaction with Treatment Experience Questionnaire (ASTEQ) Using Data from a Phase 3B Study of an Intraocular Implant for Open-Angle Glaucoma (OAG) and Ocular Hypertension (OHT)

    Jun 1, 2024, 00:00

  • SA54 Expanding the Horizon of Cost-Effectiveness Analysis: A Comprehensive Review of Alternative Methods

    Jun 1, 2024, 00:00

  • PCR52 Early Real-World Experience With Abrilada Within the Canadian Patient Population

    Jun 1, 2024, 00:00

  • EE433 Why Economic Methods for Discounting Are Wrong, What Are the Consequences, and How to Fix It

    Jun 1, 2024, 00:00

  • PCR184 Survey of Pregnant Women's Awareness and Compliance with Antenatal Care in the Light of Health Literacy

    Jun 1, 2024, 00:00

  • EE387 Healthcare Resource Utilization for Patients With Alzheimer's Disease Versus Non-Alzheimer's Disease Controls in Israel

    Jun 1, 2024, 00:00

  • PCR221 Sunbathing Habits, Knowledge A Level, and Sun Protection Related to Skin Cancers Among Adults

    Jun 1, 2024, 00:00

  • RWD84 Changes in the Number of Hysterectomy Performed in Europe between 2010-2021

    Jun 1, 2024, 00:00

  • PCR118 Education and Employment Among Individuals with Duchenne Muscular Dystrophy: Results from a Caregiver Survey

    Jun 1, 2024, 00:00

  • EE118 Impact of Different Thresholds on Recommendations Made Through Cost-Effectiveness Studies: An Example From Chronic Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • CO66 Optimizing GPT-4 Prompts for Population Eligibility Screening in COA Landscape Reviews of Qualitative Studies

    Jun 1, 2024, 00:00

  • PCR85 Are There Differences in the Sociodemographic Characteristics of Total Hip Arthroplasty Patients in Public and Private Health Care?

    Jun 1, 2024, 00:00

  • Healthcare Simulation Modeling in HEOR

    Jun 1, 2024, 00:00

  • EE505 Predictive Analysis Comparing Economic and Clinical Consequences of Treatment-related Hepatotoxicity in KRASG12C-mutated Advanced Non-small Cell Lung Cancer (aNSCLC) Patients Treated Post-immunotherapy (IO)

    Jun 1, 2024, 00:00

  • HSD81 Impact of Specialty Pharmacy: A Study in Inflammatory Conditions

    Jun 1, 2024, 00:00

  • PCR68 Disparate Barriers to Care Among Ovarian Cancer Patients in Managing Their Sleep Disturbance and Fatigue

    Jun 1, 2024, 00:00

  • HSD50 Time to Treatment Initiation By Diagnostic and Treatment Patterns Among Sarcoidosis Patients in a Real-World Hybrid Claims Database

    Jun 1, 2024, 00:00

  • HSD84 Prescription Contraceptive Use Among Medicaid-Insured Women With Obesity in the United States

    Jun 1, 2024, 00:00

  • EE475 The Benefit-Cost Analysis Adjustment Through the Generalized Risk-Adjustment Cost-Effectiveness (GRACE) Framework: An Application on Acute Ischemic Stroke Patients

    Jun 1, 2024, 00:00

  • EE509 Association between Body Mass Index and Medical Cost Among U.S. Adults in 2022

    Jun 1, 2024, 00:00

  • EE255 Costs and Healthcare Resource Utilization Evaluation in Myotonic Dystrophy Type 1: Results from the Real-World Care-DM1 Study

    Jun 1, 2024, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16 (current)
  • 17
  • 18
  • 19
  • 20
  • »